Heart Attack Elevates Risk of Breast Cancer Recurrence: Study
Heart Attack Elevates Risk of Breast Cancer Recurrence: Study
Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.
Heart Attack Elevates Risk of Breast Cancer Recurrence: Study
Heart Attack Elevates Risk of Breast Cancer Recurrence: Study

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

oncology
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
The Scientist Creative Services Team | Aug 4, 2020
Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!
A New Molecular Mechanism for Metastasis
A New Molecular Mechanism for Metastasis
The Scientist Creative Services Team | Jul 27, 2020
Download this research summary to learn about functional proteomic adaptations leading to increased metastasis!
Paul Marks, Past President of MSKCC, Dies
Paul Marks, Past President of MSKCC, Dies
Catherine Offord | May 8, 2020
A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Who Benefits from Herceptin and Other Anti-HER2 Cancer Therapies?
Robert Fortner | Apr 12, 2020
Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.
Biochemist Stanley Cohen Dies
Biochemist Stanley Cohen Dies
Catherine Offord | Feb 10, 2020
The Vanderbilt University professor was awarded a Nobel Prize for his discovery of epidermal growth factor.
Trump Picks Cancer Researcher Stephen Hahn for FDA Commissioner
Trump Picks Cancer Researcher Stephen Hahn for FDA Commissioner
Emily Makowski | Nov 4, 2019
The radiation oncologist and chief medical executive at MD Anderson Cancer Center has not worked in government previously.
Smart Pills Help Monitor Cancer Patients’ Therapy
Smart Pills Help Monitor Cancer Patients’ Therapy
Chia-Yi Hou | Jul 15, 2019
Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.
Mardis on the Future of Clinical Genomics
Mardis on the Future of Clinical Genomics
The Scientist Staff | Jul 15, 2019
Meet researcher Elaine Mardis of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Ohio and coauthor of a feature article on cancer vaccines.
Tumor Organoids Hold Promise for Personalizing Cancer Therapy
Tumor Organoids Hold Promise for Personalizing Cancer Therapy
Jef Akst | Jul 15, 2019
The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.